Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 USD | +1.96% | -1.43% | +122.43% |
May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.